(Press-News.org) JULY 29, 2025--The idea that herpes infections trigger or contribute to Alzheimer’s disease has been gaining favor among some scientists, raising hope that herpes treatments could slow progression of Alzheimer’s symptoms among patients.
But the first clinical trial to test that theory has found that a common antiviral for herpes simplex infections, valacyclovir, does not change the course of the disease for patients in the early stages of Alzheimer's.
Results from the trial, led by researchers at Columbia University Vagelos College of Physicians and Surgeons, were presented July 29 at the Alzheimer’s Association International Conference.
Possible link between herpes viruses and Alzheimer’s disease
Approximately 60% to 70% of Americans are infected with herpes simplex viruses, which cause cold sores (usually HSV1) and genital herpes (HSV2). After signs of the initial infection subside, the viruses remain dormantwithin the nervous system and can periodically reactivate, causing symptoms to flare up.
Various studies have found connections between herpes infections and Alzheimer’s, including an autopsy study that found HSV1 DNA was often associated with amyloid plaques in the brains of people diagnosed with Alzheimer’s. Additional studies have found that people treated for herpes infections were less likely to be later diagnosed with Alzheimer’s than HSV-positive people who received no antiviral treatment.
“Based on those previous studies, there was hope that valacyclovir could have an effect,” says the trial’s lead investigator, D.P. Devanand, MD, professor of psychiatry and neurology and director of geriatric psychiatry.
“But no one had conducted a clinical trial to test the idea.”
Trial details
The trial included 120 adults, age 71 on average, all diagnosed with early Alzheimer’s disease or mild cognitive impairment with imaging or blood tests that indicated Alzheimer’s pathology. All participants had antibodies revealing past herpes infections (mostly HSV1, some HSV2).
The participants were randomly assigned to take daily pills containing either valacyclovir or a placebo. The researchers measured the patients’ memory functions and imaged the brain to look for amyloid and tau deposits associated with Alzheimer’s and other structural changes.
After 18 months, the researchers found that patients taking the placebo performed slightly better on cognitive tests than the valacyclovir group, but no other measures were significantly different.
“We were looking for a signal that the drug did better than the placebo, but there wasn’t any in this study,” Devanand says. “On the other measures, sometimes the placebo group did slightly better, sometimes the treatment group did slightly better.”
Grouping participants by age, sex, and apolipoprotein E e4 status did not affect the results.
“Our trial suggests antivirals that target herpes are not effective in treating early Alzheimer’s and cannot be recommended to treat such patients with evidence of prior HSV infection. We do not know if long-term antiviral medication treatment following herpes infection can prevent Alzheimer’s because prospective controlled trials have not been conducted.”
Additional information
The study, titled “Antiviral Therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Clinical Trial, was presented July 29 at the Alzheimer’s Association International Conference in Toronto, Canada.
Authors: Davangere P. Devanand (Columbia University), Thomas Wisniewski (New York University Medical Center), Qolamreza Razlighi (Weill Cornell Medical Center), Min Qian (Columbia), Renjie Wei (Columbia), Edward P. Acosta (University of Alabama), Karen L. Bell (Columbia), Allison C. Perrin (University of Arizona), and Edward D. Huey (Alpert School of Medicine of Brown University).
The study was supported by grants from the National Institutes of Health (R01AG055422 and P30AG066512) and the Alzheimer's Association.
END
Antiviral treatment fails to slow early-stage Alzheimer’s
2025-07-29
ELSE PRESS RELEASES FROM THIS DATE:
Can African countries meet 2030 childhood immunization goals?
2025-07-29
In the last two decades, childhood immunization coverage improved significantly across most African countries. However, at least 12 countries are unlikely to achieve global targets for full immunization by 2030, according to a new study publishing July 29th in the open-access journal PLOS Medicine by Phuong The Nguyen of Hitotsubashi University, Japan, and colleagues.
Vaccines are one of the most effective ways to protect children from deadly diseases, yet immunization coverage is still suboptimal in many African countries. Monitoring and progress in childhood immunizations at the national and local level is essential for refining health programs and achieving ...
Low pre-pregnancy blood sugar linked with higher risk of preterm birth, other risks
2025-07-29
An analysis of data from more than 4.7 million Chinese women showed that those who had low blood sugar levels prior to conception were more likely to have certain adverse pregnancy outcomes—such as their baby being born preterm or with low birth weight. Hanbin Wu of the Chinese University of Hong Kong, in collaboration with the National Research Institute for Family Planning, presents these findings on July 29th in the open-access journal PLOS Medicine.
Glucose, a type of sugar, is the body’s main energy source. When blood levels of glucose are too high (known as hyperglycemia and found in prediabetes and type 2 diabetes) or too low (hypoglycemia), health risks may arise. ...
AI reveals language links between Reddit groups for hate speech, psychiatric disorders
2025-07-29
A new analysis suggests that posts in hate speech communities on the social media website Reddit share speech-pattern similarities with posts in Reddit communities for certain psychiatric disorders. Dr. Andrew William Alexander and Dr. Hongbin Wang of Texas A&M University, U.S., present these findings July 29th in the open-access journal PLOS Digital Health.
The ubiquity of social media has raised concerns about its role in spreading hate speech and misinformation, potentially contributing to prejudice, discrimination ...
A fast daily walk could extend your life: Study
2025-07-29
Walking fast for just 15 minutes per day reduced the risk of death in a large study group of mostly low-income participants.
The research findings, published July 29 in the American Journal of Preventive Medicine, support promoting brisk walking as a strategy for improving health outcomes in all communities.
Although the health benefits of walking are widely recognized, there has been limited research on the effect of factors such as walking pace on mortality, particularly in low-income and Black populations, said the study’s senior author, ...
Genome sequencing of butterflies resolves centuries-old conundrum
2025-07-29
When conditions are just right, organisms can undergo rapid bursts of diversification, and what starts out as one species can end up as an entire family tree in the evolutionary equivalent of the blink of an eye.
A new study published in the journal Proceedings of the National Academy of Sciences shows this is what recently happened to a group of tropical South American butterflies called glasswings, which partially explains why they all tend to look alike and why scientists have historically had such a hard time telling them apart.
“These butterflies have puzzled and exasperated lepidopterists, taxonomists ...
U-M study: E-cigarettes could unravel decades of tobacco control
2025-07-29
Teens who regularly use e-cigarettes are equally as likely as their peers from the 1970s to take up cigarette smoking, despite a substantial reduction in the prevalence of teenage cigarette use over the last 50 years, according to a study co-led by the University of Michigan.
U-M researchers, in collaboration with Penn State University and Purdue University, concluded that teenagers who had never used e-cigarettes had an approximately less than 1 in 50 chance of weekly cigarette use, whereas those who had previously used e-cigarettes had more than a 1 in 10 chance. More importantly, teenagers who ...
Blending technologies may help coral offspring blossom
2025-07-29
COLUMBUS, Ohio – Coral restoration efforts could be dramatically improved with technologies that support the survival and growth of baby corals, suggests a new study.
Findings showed that two novel devices, the Underwater Zooplankton Enhancement Light Array (UZELA) and 3D printed artificial settlement modules, could together boost the population of a species of coral native to Hawaii.
In a previous study led by researchers at The Ohio State University, scientists found that UZELA successfully attracted nearby zooplankton, microscopic organisms that coral feed on. That study found that the light ...
Research alert: Cannabis use disorder triples risk of oral cancer
2025-07-29
A recent study by researchers at the University of California San Diego School of Medicine has found that individuals with cannabis use disorder (CUD) are more than three times more likely to develop oral cancer within five years compared to those without CUD. The study highlights the potential long-term health risks associated with problematic cannabis use.
In 2022, 17.7 million people reported daily or near-daily cannabis use. Though CUD requires a formal diagnosis and not all cannabis users develop the disorder, recent research suggests that as many as 3 in 10 cannabis users will develop CUD.
As cannabis becomes more widely available and socially accepted, it is essential ...
Brown University to lead national institute focused on intuitive, trustworthy AI assistants
2025-07-29
PROVIDENCE, R.I. [Brown University] — With a $20 million grant from the U.S. National Science Foundation, Brown University researchers will lead an artificial intelligence research institute aimed at developing a new generation of AI assistants capable of trustworthy, sensitive and context-aware interactions with people. Work to develop the advanced assistants is specifically motivated by the potential for use in mental and behavioral health, where trust and safety are of the utmost importance.
The AI Research Institute on Interaction for AI Assistants (ARIA) will combine research on ...
On track to produce better lab-grown burgers
2025-07-29
Beef is growing in the Petri dishes of ETH professor Ori Bar-Nur, an expert in regenerative and muscle biology. However, he hasn’t yet tasted the cultivated meat because human consumption requires official approval in Switzerland. However, Bar-Nur has colleagues who have participated in approved tastings of lab-grown beef. They describe the taste and consistency as being similar to that of real meat. After all, it is beef, the only difference being that no cow needs to be slaughtered in order to obtain it.
Bar-Nur and his team produce the meat in cell culture from bovine cells. They use precursor cells, known as myoblasts, that form muscle ...